Announcements Trials
Browse Landscape

Status

Not yet recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Conditions

Turcot syndrome 1Lymphatic Metastasis 1

Interventions

Cisplatin 127Carboplatin 127Drug Therapy 116Capecitabine 101Bevacizumab 101Oxaliplatin 99Radiotherapy 97tislelizumab 87Paclitaxel 87Cyclophosphamide 87Gemcitabine 86Specimen Handling 79pembrolizumab 77toripalimab 70Magnetic Resonance Spectroscopy 66Injections 65Fluorouracil 63sintilimab 58Surgical Procedures, Operative 58anlotinib 55Docetaxel 53130-nm albumin-bound paclitaxel 51fludarabine 47Pemetrexed 46Standard of Care 45Immune Checkpoint Inhibitors 45Leucovorin 43Blood Specimen Collection 43Biopsy 43venetoclax 42

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × DNA Mismatch Repair × Clear all
NCT07625735 2026-06-04

MMR Status Modulates the Predictive Value of Lymphatic Invasion for Lymph Node Metastasis in Gastric Cancer

Shanghai Zhongshan Hospital

Not yet recruiting
3,000 enrolled

Turcot syndrome, Lymphatic Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡